bioAffinity Technologies (BIAFW) Other financing activities (2021 - 2026)

bioAffinity Technologies has disclosed Other financing activities across 6 years of filings, most recently posting $14340.0 for Q1 2026.

• In Q1 2026, Other financing activities fell 95.61% year-over-year to $14340.0; the TTM figure through Mar 2026 stood at $35022.0 (down 97.32% YoY), while the FY2025 annual figure was $347298.0, down 72.48% from the prior year.
• Other financing activities advanced to $14340.0 in Q1 2026, from -$258057.0 in the prior quarter.
• Over the last five years, Other financing activities for BIAFW reached as high as $506304.0 in Q4 2024 and fell as low as -$258057.0 in Q4 2025.
• The 5-year median for Other financing activities is $170255.0 (2023), against an average of $142824.1.
• Annual changes were most pronounced in 2023 — Other financing activities soared 538.02% — and 2025, when it plunged 150.97%.
• A 5-year view of Other financing activities shows it stood at -$156094.0 in 2022, then jumped by 250.24% to $234510.0 in 2023, then soared by 115.9% to $506304.0 in 2024, then sank by 150.97% to -$258057.0 in 2025, then soared by 105.56% to $14340.0 in 2026.
• According to Business Quant data, Other financing activities over the past three periods registered $14340.0, -$258057.0, and $67132.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.